Recurrence of invasive breast cancer carcinoma ductal breast. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Axilla Tumor Cells, Cultured Lymph Nodes Mammary Glands, Human Nipples MCF-7 Cells Epithelial Cells Pancreatic Ducts Mammary Glands, Animal Neoplastic Stem Cells

Organisms2

Mice, Nude Mice, SCID

Diseases56

Carcinoma, Ductal, Breast Breast Neoplasms Carcinoma, Intraductal, Noninfiltrating Neoplasm Invasiveness Carcinoma, Ductal Carcinoma, Lobular Carcinoma Carcinoma in Situ Neoplasm Recurrence, Local Recurrence Lymphatic Metastasis Breast Diseases Neoplasm Metastasis Carcinoma, Squamous Cell Breast Neoplasms, Male Carcinoma, Hepatocellular Disease Progression Fibrocystic Breast Disease Genetic Predisposition to Disease Adenocarcinoma Neoplasms, Hormone-Dependent Neoplasms, Ductal, Lobular, and Medullary Mammary Neoplasms, Experimental Liver Neoplasms Ovarian Neoplasms Lung Neoplasms Carcinoma, Papillary Neoplasms, Second Primary Adenocarcinoma, Mucinous Fibroadenoma Hyperplasia Cell Transformation, Neoplastic Colonic Neoplasms Precancerous Conditions Neoplasms Neovascularization, Pathologic Carcinoma, Basal Cell Bone Neoplasms Stomach Neoplasms Neoplasms, Basal Cell Prostatic Neoplasms Neoplasms, Multiple Primary Carcinoma, Transitional Cell Urinary Bladder Neoplasms Uterine Cervical Neoplasms Carcinoma, Medullary Carcinoma, Small Cell Colorectal Neoplasms Triple Negative Breast Neoplasms Thyroid Neoplasms Pancreatic Neoplasms Inflammatory Breast Neoplasms Head and Neck Neoplasms Endometrial Neoplasms Esophageal Neoplasms Skin Neoplasms

Chemicals and Drugs47

Receptors, Estrogen Receptor, erbB-2 Receptors, Progesterone Tumor Markers, Biological Ki-67 Antigen Tamoxifen Antineoplastic Agents, Hormonal Neoplasm Proteins Raloxifene Cadherins Antineoplastic Agents RNA, Messenger Selective Estrogen Receptor Modulators Estrogen Receptor alpha Estrogens DNA, Neoplasm Keratin-6 BRCA2 Protein Keratin-5 Estrogen Receptor Modulators BRCA1 Protein Tumor Suppressor Protein p53 Aromatase Inhibitors Receptor, Epidermal Growth Factor Antigens, Neoplasm Progestins Antibodies, Monoclonal Metallothionein Antibodies, Monoclonal, Humanized Keratins Estrogen Antagonists Tumor Suppressor Proteins RNA, Small Interfering Fluorouracil Transcription Factors RNA, Neoplasm Dydrogesterone Estradiol Anticarcinogenic Agents Cyclophosphamide Cyclin D1 Mucin-1 Nuclear Proteins Epirubicin Nitriles DNA-Binding Proteins DNA Primers

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Immunohistochemistry Prognosis Neoplasm Staging Mammography Mastectomy Mastectomy, Segmental Risk Factors Retrospective Studies Survival Analysis Follow-Up Studies Case-Control Studies Disease-Free Survival Incidence Treatment Outcome Tissue Array Analysis Survival Rate Chemotherapy, Adjuvant Multivariate Analysis Immunoenzyme Techniques Risk Assessment Cohort Studies Neoplasm Grading Proportional Hazards Models Prospective Studies Risk Gene Expression Profiling Odds Ratio SEER Program Early Detection of Cancer Kaplan-Meier Estimate Predictive Value of Tests Reverse Transcriptase Polymerase Chain Reaction Registries Ultrasonography, Mammary Radiotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Sensitivity and Specificity Estrogen Replacement Therapy Mass Screening Sentinel Lymph Node Biopsy Mammary Neoplasms, Experimental Lymph Node Excision In Situ Hybridization, Fluorescence Biopsy, Needle Tumor Burden Breast Self-Examination Mammaplasty Hormone Replacement Therapy Logistic Models Reproducibility of Results Biopsy Blotting, Western Neoadjuvant Therapy Oligonucleotide Array Sequence Analysis Mastectomy, Modified Radical Neoplasm Transplantation Confidence Intervals Mastectomy, Radical Questionnaires Breast Implants Radiotherapy Polymerase Chain Reaction Xenograft Model Antitumor Assays Transplantation, Heterologous Biopsy, Large-Core Needle Transfection Mitotic Index Chi-Square Distribution Reproductive History Probability Randomized Controlled Trials as Topic In Situ Hybridization False Negative Reactions Pilot Projects ROC Curve Cluster Analysis DNA Mutational Analysis

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Postmenopause Premenopause Genes, BRCA1 Risk Genes, erbB-2 Time Factors Breast Feeding Cell Proliferation Menopause Odds Ratio Genetic Predisposition to Disease Sensitivity and Specificity Drug Resistance, Neoplasm Cell Movement Mutation Gene Amplification Apoptosis Signal Transduction Genes, BRCA2 Cell Division Germ-Line Mutation Parity Genotype Down-Regulation Up-Regulation Genes, Tumor Suppressor Gene Expression Phenotype Promoter Regions, Genetic Polymorphism, Genetic Transfection DNA Methylation Chi-Square Distribution Cell Growth Processes Polymorphism, Single Nucleotide Probability Genes, p53 Phosphorylation Loss of Heterozygosity Base Sequence Alleles RNA Interference Gene Silencing Dose-Response Relationship, Drug Cell Cycle Diet

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Age Distribution Quality of Life

Humanities1

Quality of Life

Information Science7

Incidence Survival Rate SEER Program Registries Questionnaires Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care40

Risk Factors Retrospective Studies Survival Analysis Follow-Up Studies Case-Control Studies Disease-Free Survival Incidence Treatment Outcome Survival Rate Multivariate Analysis Risk Assessment Cohort Studies Proportional Hazards Models Prospective Studies Risk Age Factors Odds Ratio SEER Program Kaplan-Meier Estimate Predictive Value of Tests Registries Sensitivity and Specificity Mass Screening Logistic Models Reproducibility of Results Confidence Intervals Parity Questionnaires Confounding Factors (Epidemiology)Chi-Square Distribution Reproductive History Age Distribution Probability Randomized Controlled Trials as Topic Women's Health Age of Onset Pilot Projects Family Health ROC Curve Cluster Analysis

Geographicals5

United States California New Hampshire Sweden Wisconsin

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Carcinoma, Ductal, Breast Breast Neoplasms Breast Carcinoma, Intraductal, Noninfiltrating Neoplasm Invasiveness Carcinoma, Ductal Receptors, Estrogen Carcinoma, Lobular Receptor, erbB-2 Receptors, Progesterone Carcinoma Immunohistochemistry Carcinoma in Situ Tumor Markers, Biological Prognosis Neoplasm Recurrence, Local Recurrence Lymphatic Metastasis Neoplasm Staging Mammography Gene Expression Regulation, Neoplastic Breast Diseases Cell Line, Tumor Ki-67 Antigen Tamoxifen Mastectomy Mastectomy, Segmental Risk Factors Neoplasm Metastasis Postmenopause Retrospective Studies Carcinoma, Squamous Cell Axilla Breast Neoplasms, Male Survival Analysis Follow-Up Studies Antineoplastic Agents, Hormonal Case-Control Studies Tumor Cells, Cultured Disease-Free Survival Carcinoma, Hepatocellular Neoplasm Proteins Raloxifene Premenopause Incidence Cadherins Treatment Outcome Tissue Array Analysis Survival Rate Chemotherapy, Adjuvant Multivariate Analysis Antineoplastic Agents Immunoenzyme Techniques Risk Assessment Cohort Studies RNA, Messenger Genes, BRCA1 Neoplasm Grading Selective Estrogen Receptor Modulators Proportional Hazards Models Prospective Studies Disease Progression Risk Genes, erbB-2 Fibrocystic Breast Disease Time Factors Age Factors Breast Feeding Gene Expression Profiling Cell Proliferation Menopause Odds Ratio SEER Program Early Detection of Cancer Kaplan-Meier Estimate Mice, Nude Predictive Value of Tests Estrogen Receptor alpha Lymph Nodes Reverse Transcriptase Polymerase Chain Reaction Estrogens Genetic Predisposition to Disease Registries DNA, Neoplasm Mammary Glands, Human Adenocarcinoma Ultrasonography, Mammary Radiotherapy, Adjuvant Neoplasms, Hormone-Dependent Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Neoplasms, Ductal, Lobular, and Medullary Sensitivity and Specificity Estrogen Replacement Therapy Keratin-6 Mass Screening Sentinel Lymph Node Biopsy Nipples United States BRCA2 Protein

No FAQ available that match "recurrence of invasive breast cancer carcinoma ductal breast"